Inflammation and Cardiovascular Disease: The Future
Despite considerable advances in reducing the global burden of atherosclerotic cardiovascular disease by targeting conventional risk factors, significant residual risk remains, with low-grade inflammation being one of the strongest risk modifiers. Inflammatory processes within the arterial wall or s...
Guardado en:
Autores principales: | Natalie Arnold, Katharina Lechner, Christoph Waldeyer, Michael D Shapiro, Wolfgang Koenig |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Radcliffe Medical Media
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c298196d799e49f5b196ebfb168e1c33 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cardiovascular Medical Education During the Coronavirus Disease 2019 Pandemic: Challenges, Adaptations, and Considerations for the Future
por: Hilary Shapiro, et al.
Publicado: (2021) -
Atherosclerotic Cardiovascular Disease in Rheumatoid Arthritis: Impact of Inflammation and Antirheumatic Treatment
por: Anne Mirjam Kerola, et al.
Publicado: (2021) -
Assessing Atherosclerotic Cardiovascular Disease Risk with Advanced Lipid Testing: State of the Science
por: Charles Amir German, et al.
Publicado: (2020) -
Current Evidence and Future Directions of PCSK9 Inhibition
por: Jiaqian Xu, et al.
Publicado: (2021) -
The Role of Inflammation in Diabetes: Current Concepts and Future Perspectives
por: Sotirios Tsalamandris, et al.
Publicado: (2019)